The main functions of the Council on Science and Public Health (CSAPH) are to advise on substantial and promising developments, and to assist in developing policy positions on scientific aspects of medicine, public health, and biomedical research that warrant the attention of the profession, the public, and the public/private sector.
The primary method of developing evidence-based policy positions and recommendations is the drafting of reports for the House of Delegates. Topics for CSAPH reports can be the result of AMA House of Delegates action or chosen and initiated, in the case of an emerging scientific or public health area or policy gap, by the Council.
CSAPH bases the policy recommendations presented in reports on a review and evaluation of relevant sources detailing the evidence-base and current knowledge of a topic. Sources include peer-reviewed literature, expert papers, commentaries, special publications, expert meeting and workshop proceedings, and stakeholder outreach.
Reports by topic
Some topics that have been addressed by CSAPH include environmental health, various drug issues, vaccinations, genetic and precision medicine, child safety, and public health matters.
- Child safety CSAPH reports
- Environmental health CSAPH reports
- Genetic medicine CSAPH reports
- Physician safety CSAPH reports
- Prescription drugs CSAPH reports
- Public health CSAPH reports
- Vaccinations CSAPH reports
Reports by year
Access the CSAPH reports by year. For reports prior to 2007, access the AMA archive.
- 2025 reports
- Addressing Social Determinants of Health Through Closed Loop Referral Systems (CSAPH Report 2-A-25)
- Protections Against Surgical Smoke Exposure (CSAPH Report 3-A-25)
- Screening for Image Manipulation in Research Publications (CSAPH Report 5-A-25)
- Addressing the Health Issues Unique to Minority Communities in Rural Areas (CSAPH Report 7-A-25)
- Explainability of Artificial/Augmented Intelligence and Machine Learning Algorithms (PDF) (CSAPH Report 8-A-25)
- 2023 reports
- Improving Research Standards, Approval Processes, and Post-Market Surveillance Standards for Medical Devices (PDF) CSAPH report 2-A-23
- Marketing Guardrails for the "Over-Medicalization" of Cannabis Use (PDF) CSAPH report 6-I-23
- 2022 reports
- Transformation of Rural Community Public Health Systems (CSAPH Report 2-A-22)
- 2021 reports
- Drug Shortages: 2021 Update (CSAPH 1-N-21)
- Full Commitment by our AMA to the Betterment and Strengthening of Public Health Systems (Resolution 401-JUN-21) (CSAPH 2-N-21)
- Physician Involvement in State Regulations of Motor Vehicle Operation and/or Firearm Use by Individuals with Cognitive Deficits Due to Traumatic Brain Injury (CSAPH 3-N-21)
- Pharmacovigilance (Res 518-A-19, Chemical Variability in Pharmaceutical Products) (CSAPH 4-N-21)
- 2020 reports
- Dietary Supplements: Update on Regulation, Industry, and Product Trends (CSAPH-report 3-I-20)
- 2019 reports
- Drug Shortages: Update PDF, 453.5 KB (CSAPH-report 2-A-19)
- 2018 reports
- Drug shortages: update (PDF) CSAPH-report 2-A-18
- Prescription drug donation (PDF) CSAPH-report 3-A-18
- Physician’s role in firearm safety (PDF) CSAPH-report 4-A-18
- Tobacco harm reduction (PDF) CSAPH-report 5-A-18
- Screening LGBTQ (PDF) CSAPH-report 1-I-18
- FDA expedited report (PDF) CSAPH-report 2-I-18
- Joint high value care report (PDF) CSAPH/CMS joint report I-18
- 2017 reports
- Emerging drugs of abuse are a public health threat (PDF) CSAPH report 2-A-17
- Strategies to reduce the consumption of beverages with added sweeteners (PDF) CSAPH report 3-A-17
- Payment and coverage for genetic/genomic precision medicine (PDF) CSAPH-CMS joint report 1-I-17
- Universal color scheme for respiratory inhalers (PDF) CSAPH-report 1-I-17
- Neuropathic pain as a disease (PDF) CSAPH report 3-I-17
- National drug shortages: update (PDF) CSAPH-report 4-I-17
- Clinical implications and policy considerations of cannabis use (PDF) CSAPH report 5-I-17
- 2016 reports
- Human and environmental effects of light emitting diode (LED) community lighting (PDF) CSAPH report 2-A-16
- The precision medicine initiative (PDF) CSAPH report 3-A-16
- Powdered alcohol (PDF) CSAPH report 4-A-16
- An expanded definition of women’s health (PDF) CSAPH report 5-A-16
- Delaying School Start Time to Alleviate Adolescent Sleep Deprivation (PDF) CSAPH report 6-A-16
- Preventing violent acts against health care providers report(summary only) (PDF) CSAPH report 7-A-16
- Juvenile Justice System Reform (summary only) (PDF) CSAPH report 8-A-16
- Increasing awareness of nootropic use (PDF) CSAPH report 9-A-16
- Urine drug testing (PDF) CSAPH report 1-I-16
- National drug shortages update (PDF) CSAPH report 2-I-16
- Genome editing and its potential clinical use (PDF) CSAPH report 3-I-16
- Hormone therapies: off-label uses and unapproved formulations (PDF) CSAPH report 4-I-16
- An expanded definition of women’s health (PDF) CSAPH report 5-A-16
- 2015 reports
- Ban on Super Magnetic Toys as a Choking and Gastrointestinal Hazard to Children (PDF) CSAPH report 2-A-15
- Concussion and Youth Sports (PDF) CSAPH report 3-A-15
- Coverage for chronic pain management (CEJA/CMS joint report) (PDF) CMS/CSAPH Joint report-A-15
- Non-medical exemptions to immunizations (CEJA/CSAPH joint report) (PDF) Joint CSAPH/CEJA report A-15
- Non-medical exemptions to immunization report (PDF) CSAPH report 1-I-15
- National drug shortages update (PDF) CSAPH report 2-I-15
- Combating antibiotic resistance: an update (PDF) CSAPH report 3-I-15
- 2014 reports
- Genomic-based approaches to the risk assessment, management and prevention of type 2 diabetes (summary only) (PDF) CSAPH report 2-A-14
- National drug shortages update (PDF) CSAPH report 3-A-14
- Biosimilar product approval and marketing (summary only) (PDF) CSAPH report 4-A-14
- Guidelines for mobile medical applications and devices (PDF) CSAPH report 5-A-14
- Genomics in hypertension: risk prediction and treatment (PDF) CSAPH report 1-I-14
- Electronic cigarettes, vaping, and health: update (PDF) CSAPH report 2-I-14
- Tornado safety and manufactured homes report (PDF) CSAPH report 3-I-14
- Role of pharmacists in improving immunization rates report (PDF) CSAPH report 4-I-14
- 2013 reports
- Nanotechnology safety and regulation (PDF) CSAPH report 2-A-13
- Is obesity a disease? (PDF) CSAPH report 3-A-13
- Safety of x-ray security scanners (PDF) CSAPH report 4-A-13
- Health effects of the Gulf oil spill report (PDF) CSAPH report 5-A-13
- Electronic games and health promotion (PDF) CSAPH report 6-A-13
- Genetic discrimination and the genetic information nondiscrimination act (PDF) CSAPH report 7-A-13
- National drug shortages update (PDF) CSAPH report 8-A-13
- Pharmacy compounding (PDF) CSAPH report 9-A-13
- Inclusion of supplement purchases in nutritional assistance programs (PDF) CSAPH report 1-I-13
- A contemporary view of national drug control policy (PDF) CSAPH report 2-I-13
- 2012 reports
- Labeling of bioengineered foods (PDF) CSAPH report 2-A-12
- Safety of bottled water (PDF) CSAPH report 3-A-12
- Light pollution: adverse health effects of nighttime lighting (summary only) (PDF) CSAPH report 4-A-12
- Taxes on beverages with added sweeteners (PDF) CSAPH report 5-A-12
- Screening mammography (PDF) CSAPH report 6-A-12
- Drug shortages update (PDF) CSAPH report 7-A-12
- Use of Atypical Antipsychotics in Pediatric Patients (PDF) CSAPH report 1-I-12
- National drug shortages update (PDF) CSAPH report 2-I-12
- Risk evaluation and mitigation strategies (PDF) CSAPH report 3-I-12
- Clinical application of next-generation genomic sequencing (summary only) (PDF) CSAPH report 4-I-12
- AMA policy consolidation: influenza and influenza vaccine report (PDF) CSAPH report 5-I-12
- 2011 reports
- Physician health programs report (PDF) CSAPH report 2-A-11
- Consumer medication information (PDF) CSAPH report 3-A-11
- Dietary intake of incarcerated populations (PDF) CSAPH report 4-A-11
- Bisphenol A report (PDF) CSAPH report 5-A-11
- An abbreviated approval pathway for biosimilars (PDF) CSAPH report 1-I-11
- National drug shortages (PDF) CSAPH report 2-I-11
- 2010 reports
- Suicide in physicians and physicians-in-training report (PDF) CSAPH report 2-A-10
- Update on the food and drug administration's (FDA) efforts to improve food safety (PDF) CSAPH report 3-A-10
- Genomic-based personalized medicine (PDF) CSAPH report 4-A-10
- Maldynia: pathophysiology and non-pharmacologic treatment (PDF) CSAPH report 5-A-10
- Use of electronic cigarettes in smoking cessation programs (PDF) CSAPH report 6-A-10
- Lead Levels in Children (PDF) CSAPH report 7-A-10
- The evolving culture of drug safety in the united states: risk evaluation and mitigation strategies (REMS) (PDF) CSAPH report 8-A-10
- Physician health programs report (PDF) CSAPH report 1-I-10
- Violence in the emergency department report (PDF) CSAPH report 2-I-10
- Gulf oil spill health risks: Update on AMA involvement report (PDF) CSAPH report 3-I-10
- 2009 reports
- Male breast cancer (PDF) CSAPH report 2-A-09
- Disparities in maternal mortality (PDF) CSAPH report 3-A-09
- Appropriate supplementation of Vitamin D (PDF) CSAPH report 4-A-09
- The use of hormones for "antiaging": a review of efficacy and safety (PDF) CSAPH report 5-A-09
- Use of tasers® by law enforcement agencies (PDF) CSAPH report 6-A-09
- An updated review of sex education programs in the United States (PDF) CSAPH report 7-A-09
- Sustainable food (PDF) CSAPH report 8-A-09
- Health care disparities in same-sex households (PDF) CSAPH report 1-I-09
- Identifying and Reporting Suspected Child Abuse (PDF) CSAPH report 2-I-09
- Use of cannabis for medicinal purposes (PDF) CSAPH report 3-I-09
- 2008 reports
- The clinical utility of measuring body mass index and waist circumference in the diagnosis and management of adult overweight and obesity (PDF) CSAPH report 1-A-08
- The health effects of high fructose syrup (PDF) CSAPH report 3-A-08
- Ensuring the Best In-School Care for Children with Diabetes (PDF) CSAPH report 4-A-08
- Revision of the lifetime deferral for blood donation of the men who have sex with men (MSM) population (PDF) CSAPH report 5-A-08
- Portable listening devices and noise-induced hearing loss (PDF) CSAPH report 6-A-08
- Elder mistreatment (PDF) CSAPH report 7-A-08
- Substance use and substance use disorders (PDF) CSAPH report 8-A-08
- Optimizing care for gay men and lesbians (PDF) CSAPH report 9-A-08
- Green initiatives and the health care community report (PDF) CSAPH report 1-I-08
- Improving medical practice and patient/family education to reverse the epidemic of nonmedical prescription drug use and addiction (PDF) CSAPH report 2-I-08
- Global climate change and human health report (PDF) CSAPH report 3-I-08
- Financing of adult vaccines: recommendations for action report (PDF) CSAPH report 4-I-08
- 2007 reports
- Generic substitution of narrow therapeutic index drugs (PDF) CSAPH report 2-A-07
- Expansion of hazardous waste landfills over aquifers report (PDF) CSAPH report 4-A-07
- Radioactive/chemical waste and radiation in the environment report (PDF) CSAPH report 5-A-07
- Standards, laws, and regulations addressing pain medications and medical practice (PDF) CSAPH report 6-A-07
- Hematopoietic stem cell transplantation: utilization of and minority representation on the national bone marrow donor registry (PDF) CSAPH report 7-A-07
- Eating disorders and promotion of healthy body image (PDF) CSAPH report 8-A-07
- Home anticoagulation monitoring (PDF) CSAPH report 9-A-07
- Attention deficit hyperactivity disorder (PDF) CSAPH report 10-A-07
- Emotional and Behavioral Effects of Video Games and Internet Overuse (PDF) CSAPH report 12-A-07
- Use of Serotonin Reuptake Inhibitors in Pregnancy (PDF) CSAPH report 13-A-07
- AMA policy on smoke-free environments and workplaces (PDF) CSAPH report 1-I-07
- Update on Youth and School Violence (PDF) CSAPH report 2-I-07
